Carregant...
Rapid identification and evaluation of neoantigen-reactive T cell receptors from single cells.
Engineered T cells expressing tumor-specific T cell receptors (TCRs) are emerging as a mode of personalized cancer immunotherapy that requires identification of TCRs against the products of known driver mutations and novel mutations in a timely fashion. We present a non-viral and non-next generation...
Guardat en:
| Publicat a: | J Immunother |
|---|---|
| Autors principals: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7725897/ https://ncbi.nlm.nih.gov/pubmed/33086340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000342 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|